ChipsYahoo Financeabout 8 hours ago
Eli Lilly ranks among most profitable blue chips
1 min read
Eli Lilly posted a 34.99% profit margin and $20.64 billion net income in FY25, ranking among the most profitable blue chip stocks for hedge funds. The FDA approved a new every-eight-week maintenance dose for EBGLYSS. Foundayo outperformed oral semaglutide on A1C and weight loss in the ACHIEVE-3 trial.
Level
Hype check
Tap to vote and see what everyone thinks.
